HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas

Oncotarget

Volumn 7, Issue 12, 2016, Pages 14429-14440

  Zhu, Yu ^a   Zhang, Xuebin ^a   Qi, Lisha ^b   Cai, Ying ^a   Yang, Ping ^a   Xuan, Geng ^b   Jiang, Yuan ^b  

^a TIANJIN HUANHU HOSPITAL   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Anoikis; Glioma; HULC; IncRNA; Proliferation

Indexed keywords

ENDOTHELIAL CELL SPECIFIC MOLECULE 1; HIGHLY UPREGULATED IN LIVER CANCER; LONG UNTRANSLATED RNA; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; VASCULOTROPIN; AKT1 PROTEIN, HUMAN; ESM1 PROTEIN, HUMAN; HULC LONG NON-CODING RNA, HUMAN; MTOR PROTEIN, HUMAN; PROTEOGLYCAN; TARGET OF RAPAMYCIN KINASE; TUMOR MARKER; TUMOR PROTEIN;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ANOIKIS; ARTICLE; CAPILLARY DENSITY; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; APOPTOSIS; CANCER STAGING; CELL MOTION; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; TUMOR CELL CULTURE; VASCULARIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; APOPTOSIS; BIOMARKERS, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84971643983     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7418     Document Type: Article

References (30)

1. Cui M, Xiao Z, Wang Y, Zheng M, Song T, Cai X, Sun B, Ye L, Zhang X. Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway. Cancer Res. 2015; 75:846-857. doi: 10.1158/0008-5472. CAN-14-1192.
2. Kang M, Sang Y, Gu H, Zheng L, Wang L, Liu C, Shi Y, Shao A, Ding G, Chen S, Tang W, Yin J. Long noncoding RNAs POLR2E rs3787016 C/T and HULC rs7763881 A/C polymorphisms are associated with decreased risk of esophageal cancer. Tumour Biol. 2015; 36:6401-6418. doi: 10.1007/s13277-015-3328-z.
3. Yang X, Xie X, Xiao YF, Xie R, Hu CJ, Tang B, Li BS, Yang SM. The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma. Cancer Lett. 2015; 360:119-124. doi: 10.1016/j.canlet.2015.02.035.
4. Peng W, Gao W, Feng J. Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer. Med Oncol. 2014; 31:346. doi: 10.1007/s12032-014-0346-4.
5. Zhao Y, Guo Q, Chen J, Hu J, Wang S, Sun Y. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol Rep. 2014; 31:358-364. doi: 10.3892/or.2013.2850.
6. Frisch SM. E1a induces the expression of epithelial characteristics. J Cell Biol 1994; 4:1085-1096.
7. Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013; 1833:3481-3498. doi: 10.1016/j.bbamcr.2013.06.026.
8. Liotta LA, Kohn E. Anoikis: cancer and the homeless cell. Nature. 2004; 430:973-974. doi: 10.1038/430973a.
9. Stanisavljevic J, Loubat-Casanovas J, Herrera M, Luque T, Peña R, Lluch A, Albanell J, Bonilla F, Rovira A, Peña C, Navajas D, Rojo F, García de Herreros A, et al. Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasis. Cancer Res. 2015; 75:284-295. doi: 10.1158/0008-5472.CAN-14-1903.
10. Winitthana T, Lawanprasert S, Chanvorachote P. Triclosan potentiates epithelial-to-mesenchymal transition in anoikis-resistant human lung cancer cells. PLOS ONE. 2014; 9: e110851. doi: 10.1371/journal.pone.0110851.
11. Guru SK, Pathania AS, Kumar S, Ramesh D, Kumar M, Rana S, Kumar A, Malik F, Sharma PR, Chandan BK, Jaglan S, Sharma JP, Shah BA, etal. Secalonic acid-D represses HIF1α/VEGF-Mediated angiogenesis by regulating the Akt/mTOR/p70S6K signaling cascade. Cancer Res. 2015; 75:2886-2896. doi: 10.1158/0008-5472.CAN-14-2312.
12. Goodenberger ML, Jenkins RB Genetics of adult glioma. Cancer Genet. 2012; 205:613-621. doi: 10.1016/j.cancergen.2012.10.009.
13. Zhao Y, Sun Y, Zhang H, Liu X, Du W, Li Y, Zhang J, Chen L, Jiang C. HGF/MET signaling promotes glioma growth via up-regulation of cox-2 expression and PGE2 production. Int J Clin Exp Pathol. 2015; 8:3719-3726.
14. Li S, Lv Q, Sun H, Xue Y, Wang P, Liu L, Li Z, Li Z, Tian X, Liu YH. Expression of TRAP1 predicts poor survival of malignant glioma patients. J Mol Neurosci. 2015; 55:62-68. doi: 10.1007/s12031-014-0413-5.
15. Vassallo I, Zinn P, Lai M, Rajakannu P, Hamou MF, Hegi ME. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. Oncogene. 2015 Mar 16. doi: 10.1038/onc.2015.61. [Epub ahead of print]
16. Zhang K, Sun X, Zhou X, Han L, Chen L, Shi Z, Zhang A, Ye M, Wang Q, Liu C, Wei J, Ren Y, Yang J, etal. Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2dependent manner. Oncotarget. 2015; 1:537-546. doi: 10.18632/oncotarget.2681.
17. Cao P, Feng F, Dong G, Yu C, Feng S, Song E, Shi G, Liang Y, Liang G. Estrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner. BMC Cancer. 2015; 15:491. doi: 10.1186/s12885-015-1495-3.
18. Li W, Qi Z, Wei Z, Liu S, Wang P, Chen Y, Zhao Y. Paeoniflorin inhibits proliferation and induces apoptosis of human glioma cells via microRNA-16 upregulation and matrix metalloproteinase-9downregulation. Mol Med Rep. 215; 12:2735-2740. doi: 10.3892/mmr.2015.3718.
19. Zhang L, Zhang Y. Tunneling nanotubes between rat primary astrocytes and C6glioma cells alter proliferation potential of glioma cells. Neurosci Bull. 2015; 31:371-378. doi: 10.1007/s12264-014-1522-4.
20. Yan S, Han X, Xue H, Zhang P, Guo X, Li T, Guo X, Yuan G, Deng L, Li G. Let-7f inhibits glioma cell proliferation, migration, and invasion by targeting Periostin. J Cell Biochem. 2015; 116:1680-1692. doi: 10.1002/jcb.25128.
21. Kundu ST, Byers LA, Peng DH, Roybal JD, Diao L, Wang J, Tong P, Creighton CJ, Gibbons DL. The miR-200 family and the miR-183~96~182 cluster target Foxf2to inhibit invasion and metastasis in lung cancers. Oncogene. 2015 Mar 23. doi: 10.1038/onc.2015.71. [Epub ahead of print].
22. Cai J, Tian AX, Wang QS, Kong PZ, Du X, Li XQ, Feng YM. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer. Cancer Lett. 2015; 367:129-137. doi: 10.1016/j.canlet.2015.07.001.
23. Rosen K, Shi W, Calabretta B, Filmus J. Cell detachment triggers p38mitogen-activated protein kinase-dependent overexpression of Fas ligand. A novel mechanism of Anoikis of intestinal epithelial cells. J Biol Chem. 2002; 48:46123-46130.
24. Cai H, Xue Y, Li Z, Hu Y, Wang Z, Liu W, Li Z, Liu Y. Roundabout4 suppresses glioma-induced endothelial cell proliferation, migration and tube formation in vitro by inhibiting VEGR2-mediated PI3K/AKT and FAK signaling pathways. Cell Physiol Biochem. 2015; 35:1689-1705. doi: 10.1159/000373982.
25. Brocard E, Oizel K, Lalier L, Pecqueur C, Paris F, Vallette FM, Oliver L. Radiation-induced PGE2 sustains human glioma cells growth and survival through EGF signaling. Oncotarget. 2015; 6:6840-6849. doi: 10.18632/oncotarget.3160.
26. Wang G, Dai F, Yu K, Jia Z, Zhang A, Huang Q, Kang C, Jiang H, Pu P. Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways. Int J Oncol. 2015; 46:1739-1747. doi: 10.3892/ijo.2015.2863.
27. Goschzik T, Gessi M, Denkhaus D, Pietsch T. PTEN mutations and activation of the PI3K/Akt/mTOR signaling pathway in papillary tumors of the pineal region. J Neuropathol Exp Neurol. 2014; 73:747-751. doi: 10.1097/NEN.0000000000000093.
28. Popov TM, Goranova T, Stancheva G, Kaneva R, Dikov T, Chalakov I, Rangachev J, Konov D, Todorov S, Stoyanov O, Mitev V. Relative quantitative expression of hypoxia-inducible factor-1α, -2α and -3α, and vascular endothelial growth factor A in laryngeal carcinoma. Oncol Lett. 2015; 6:2879-2885.
29. Maurage CA, Adam E, Minéo JF, Sarrazin S, Debunne M, Siminski RM, Baroncini M, Lassalle P, Blond S, Delehedde M. Endocan expression and localization in human glioblastomas. J Neuropathol Exp Neurol. 2009; 68:633-641. doi: 10.1097/NEN.0b013e3181a52a7f.
30. Yan Z, Qu K, Zhang J, Huang Q, Qu P, Xu X, Yuan P, Huang X, Shao Y, Liu C, Zhang H, Xing J. CD147 promotes liver fibrosis progression via VEGF-A/VEGFR2 signalling-mediated cross-talk between hepatocytes and sinusoidal endothelial cells. Clin Sci (Lond). 2015; 129:699-710. doi: 10.1042/CS20140823.